114 related articles for article (PubMed ID: 15615534)
1. Potent, selective and low-calcemic inhibitors of CYP24 hydroxylase: 24-sulfoximine analogues of the hormone 1alpha,25-dihydroxyvitamin D(3).
Kahraman M; Sinishtaj S; Dolan PM; Kensler TW; Peleg S; Saha U; Chuang SS; Bernstein G; Korczak B; Posner GH
J Med Chem; 2004 Dec; 47(27):6854-63. PubMed ID: 15615534
[TBL] [Abstract][Full Text] [Related]
2. Potent, low-calcemic, selective inhibitors of CYP24 hydroxylase: 24-sulfone analogs of the hormone 1alpha,25-dihydroxyvitamin D3.
Posner GH; Crawford KR; Yang HW; Kahraman M; Jeon HB; Li H; Lee JK; Suh BC; Hatcher MA; Labonte T; Usera A; Dolan PM; Kensler TW; Peleg S; Jones G; Zhang A; Korczak B; Saha U; Chuang SS
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):5-12. PubMed ID: 15225738
[TBL] [Abstract][Full Text] [Related]
3. Noncalcemic, antiproliferative, transcriptionally active, 24-fluorinated hybrid analogues of the hormone 1alpha, 25-dihydroxyvitamin D3. Synthesis and preliminary biological evaluation.
Posner GH; Lee JK; Wang Q; Peleg S; Burke M; Brem H; Dolan P; Kensler TW
J Med Chem; 1998 Jul; 41(16):3008-14. PubMed ID: 9685240
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D analogues targeting CYP24 in chronic kidney disease.
Posner GH; Helvig C; Cuerrier D; Collop D; Kharebov A; Ryder K; Epps T; Petkovich M
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):13-9. PubMed ID: 20347976
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibitors of CYP24: mechanistic tools to explore vitamin D metabolism in human keratinocytes.
Schuster I; Egger H; Astecker N; Herzig G; Schüssler M; Vorisek G
Steroids; 2001; 66(3-5):451-62. PubMed ID: 11179754
[TBL] [Abstract][Full Text] [Related]
6. A 24-phenylsulfone analog of vitamin D inhibits 1alpha,25-dihydroxyvitamin D(3) degradation in vitamin D metabolism-competent cells.
Lechner D; Manhardt T; Bajna E; Posner GH; Cross HS
J Pharmacol Exp Ther; 2007 Mar; 320(3):1119-26. PubMed ID: 17182978
[TBL] [Abstract][Full Text] [Related]
7. Combination of vitamin D metabolites with selective inhibitors of vitamin D metabolism.
Schuster I; Egger H; Reddy GS; Vorisek G
Recent Results Cancer Res; 2003; 164():169-88. PubMed ID: 12899522
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of vitamin D hydroxylases in human keratinocytes.
Schuster I; Egger H; Bikle D; Herzig G; Reddy GS; Stuetz A; Stuetz P; Vorisek G
Steroids; 2001; 66(3-5):409-22. PubMed ID: 11179750
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of vitamin D hydroxylases: structure-activity relationships.
Schuster I; Egger H; Nussbaumer P; Kroemer RT
J Cell Biochem; 2003 Feb; 88(2):372-80. PubMed ID: 12520539
[TBL] [Abstract][Full Text] [Related]
10. Role of 24-hydroxylase in vitamin D3 growth response of OVCAR-3 ovarian cancer cells.
Miettinen S; Ahonen MH; Lou YR; Manninen T; Tuohimaa P; Syvälä H; Ylikomi T
Int J Cancer; 2004 Jan; 108(3):367-73. PubMed ID: 14648702
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of 1,25-dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25-hydroxyvitamin D3-24-hydroxylase.
Roy S; Martel J; Tenenhouse HS
J Bone Miner Res; 1995 Dec; 10(12):1951-9. PubMed ID: 8619376
[TBL] [Abstract][Full Text] [Related]
12. Metabolic studies using recombinant escherichia coli cells producing rat mitochondrial CYP24 CYP24 can convert 1alpha,25-dihydroxyvitamin D3 to calcitroic acid.
Sakaki T; Sawada N; Nonaka Y; Ohyama Y; Inouye K
Eur J Biochem; 1999 May; 262(1):43-8. PubMed ID: 10231362
[TBL] [Abstract][Full Text] [Related]
13. Low-calcemic, highly antiproliferative, 23-oxa ether analogs of the natural hormone 1 alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
Petersen KS; Dolan PM; Kensler TW; Peleg S; Posner GH
J Med Chem; 2007 Nov; 50(23):5824-32. PubMed ID: 17924616
[TBL] [Abstract][Full Text] [Related]
14. Induction of the vitamin D 24-hydroxylase (CYP24) by 1,25-dihydroxyvitamin D3 is regulated by parathyroid hormone in UMR106 osteoblastic cells.
Armbrecht HJ; Hodam TL; Boltz MA; Partridge NC; Brown AJ; Kumar VB
Endocrinology; 1998 Aug; 139(8):3375-81. PubMed ID: 9681485
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and CYP24 inhibitory activity of 2-substituted-3,4-dihydro-2H-naphthalen-1-one (tetralone) derivatives.
Yee SW; Simons C
Bioorg Med Chem Lett; 2004 Nov; 14(22):5651-4. PubMed ID: 15482941
[TBL] [Abstract][Full Text] [Related]
16. Dramatic enhancement of antagonistic activity on vitamin D receptor: a double functionalization of 1alpha-hydroxyvitamin D3 26,23-lactones.
Saito N; Saito H; Anzai M; Yoshida A; Fujishima T; Takenouchi K; Miura D; Ishizuka S; Takayama H; Kittaka A
Org Lett; 2003 Dec; 5(25):4859-62. PubMed ID: 14653692
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
18. Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
Peleg S; Petersen KS; Suh BC; Dolan P; Agoston ES; Kensler TW; Posner GH
J Med Chem; 2006 Dec; 49(25):7513-7. PubMed ID: 17149880
[TBL] [Abstract][Full Text] [Related]
19. Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D.
Anderson PH; O'Loughlin PD; May BK; Morris HA
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):111-3. PubMed ID: 15225756
[TBL] [Abstract][Full Text] [Related]
20. Conceptually new sulfone analogues of the hormone 1alpha, 25-dihydroxyvitamin D(3): synthesis and preliminary biological evaluation.
Posner GH; Wang Q; Han G; Lee JK; Crawford K; Zand S; Brem H; Peleg S; Dolan P; Kensler TW
J Med Chem; 1999 Sep; 42(18):3425-35. PubMed ID: 10479276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
